TrueBlue (TBI) Falls Short of Q4 View; Guides Down
TrueBlue, Inc (NYSE: TBI) reports Q4 EPS of $0.08 ex-impairment, 2 cents below the analyst estimate of $0.10. Revenue for the quarter was $302 million, versus the consensus of $321.40 million.
Sees Q1 sales between $220M to $230M versus consensus of $281.98 million.
Sees Q1 EPS loss 15c to 20c versus $0.02 consensus.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
